drugset / Trial / NCT04819685
Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury
Phase 4
Unknown
520 enrolled
Peking Union Medical College Hospital
Affiliated Cancer Hospital of Guizhou Medical University · collabCancer Institute and Hospital, Chinese Academy of Medical Sciences · collabChinese PLA General Hospital · collabFudan University · collabHenan Cancer Hospital · collabJiangsu Cancer Institute & Hospital · collabJilin Provincial Tumor Hospital · collabPeking University Cancer Hospital & Institute · collabPeking University Third Hospital · collabShandong Cancer Hospital and Institute · collabSichuan Cancer Hospital and Research Institute · collabSun Yat-sen University · collabThe First Affiliated Hospital of Air Force Medicial University · collabXiangya Hospital of Central South University · collabZhejiang Cancer Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
A total of 520 cases will be randomly divided into Kang Fu Pen (liquid dressing) enema intervention group (experimental group) and non-enema intervention group (control group), according to the ratio of 1:1.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2023-03-01
- Completion
- 2025-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant human superoxide dismutase | Protein / enzyme biologic | 50 ml | Other |